← Leaderboards
Elliott Paul Dawson
Bioventures, Inc.
$388,441
Attributed
$1,165,322
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$1,165,322 · 1
By mechanism
R42$1,165,322 · 1
Top collaborators
- Nicholas M Adams2 shared
- Frederick R Haselton2 shared
Most similar at Bioventures, Inc.
Same institution · by research overlap
- Nicholas M Adams$1,475,205
- Steven John Simmons$559,942
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogBaseBiological MarkersBusinessesCalibrationClia CertifiedClinicClinical DiagnosticsCommunicable DiseasesDesignDetectionDiagnosis StandardDiagnosticDiagnostic TestsDisease OutbreaksDissociationDna AnalysisDna PrimersEnantiomerEscherichia ColiEvaluationEventFailureAdoption
Grant awards (2)
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$878,071
R42 · FY2017 · HG · contact PI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$287,251
R42 · FY2017 · HG · contact PI